PrimeraDx Raises $20 Million
PrimeraDx Inc., a Mansfield, Mass.-based molecular diagnostics company, has raised $20 million in Series C funding. CHL Medical Partners led the round, and was joined by return backers Abingworth, InterWest Partners, Malaysian Technology Development Corporation, MPM Capital, Burrill & Co. and the Invus Group.
21 September 2009•2 mins read
